Enhancing adoptive T‐cell therapy with fucoidan‐based IL‐2 delivery microcapsules

• Egile Nagusiak: Eun Young Jeon (Egilea), Da‐som Choi (Egilea), Seunghyun Choi (Egilea), Ju‐young Won (Egilea), Yunju Jo (Egilea), Hye‐bin Kim (Egilea), Youngmee Jung (Egilea), Sang Chul Shin (Egilea), Hophil Min (Egilea), Hae Woong Choi (Egilea), Myeong Sup Lee (Egilea), Yoon Park (Egilea), Justin J. Chung (Egilea), Hyung‐seung Jin (Egilea)
• Formatua: Liburua
• Argitaratua: Wiley, 2023-01-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Abstract Adoptive cell therapy (ACT) with antigen‐specific T cells is a promising treatment approach for solid cancers. Interleukin‐2 (IL‐2) has been utilized in boosting the efficacy of ACT. However, the clinical applications of IL‐2 in combination with ACT is greatly limited by short exposure and...